Theralase Technologies Past Earnings Performance
Past criteria checks 0/6
Theralase Technologies has been growing earnings at an average annual rate of 7.7%, while the Medical Equipment industry saw earnings growing at 12.5% annually. Revenues have been growing at an average rate of 0.8% per year.
Key information
7.7%
Earnings growth rate
16.5%
EPS growth rate
| Medical Equipment Industry Growth | -19.2% |
| Revenue growth rate | 0.8% |
| Return on equity | -265.9% |
| Net Margin | -478.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Is Theralase Technologies (CVE:TLT) In A Good Position To Deliver On Growth Plans?
Jul 29
We're Not Very Worried About Theralase Technologies' (CVE:TLT) Cash Burn Rate
Apr 08Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation
Dec 24Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation
Sep 03Revenue & Expenses Breakdown
How Theralase Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -4 | 2 | 3 |
| 31 Mar 24 | 1 | -4 | 2 | 3 |
| 31 Dec 23 | 1 | -5 | 2 | 3 |
| 30 Sep 23 | 1 | -4 | 2 | 3 |
| 30 Jun 23 | 1 | -5 | 2 | 4 |
| 31 Mar 23 | 1 | -5 | 2 | 4 |
| 31 Dec 22 | 1 | -5 | 2 | 4 |
| 30 Sep 22 | 1 | -6 | 2 | 4 |
| 30 Jun 22 | 1 | -5 | 2 | 4 |
| 31 Mar 22 | 1 | -5 | 2 | 4 |
| 31 Dec 21 | 1 | -4 | 2 | 3 |
| 30 Sep 21 | 1 | -4 | 2 | 2 |
| 30 Jun 21 | 1 | -4 | 2 | 3 |
| 31 Mar 21 | 1 | -5 | 2 | 3 |
| 31 Dec 20 | 1 | -6 | 3 | 3 |
| 30 Sep 20 | 1 | -8 | 3 | 5 |
| 30 Jun 20 | 1 | -8 | 3 | 5 |
| 31 Mar 20 | 1 | -8 | 3 | 5 |
| 31 Dec 19 | 1 | -7 | 3 | 4 |
| 30 Sep 19 | 1 | -5 | 3 | 3 |
| 30 Jun 19 | 1 | -4 | 2 | 2 |
| 31 Mar 19 | 1 | -3 | 2 | 2 |
| 31 Dec 18 | 2 | -3 | 3 | 2 |
| 30 Sep 18 | 2 | -4 | 3 | 2 |
| 30 Jun 18 | 2 | -5 | 4 | 2 |
| 31 Mar 18 | 2 | -6 | 5 | 2 |
| 31 Dec 17 | 2 | -6 | 5 | 3 |
| 30 Sep 17 | 2 | -6 | 5 | 2 |
| 30 Jun 17 | 2 | -6 | 4 | 2 |
| 31 Mar 17 | 2 | -5 | 4 | 2 |
| 31 Dec 16 | 2 | -5 | 4 | 2 |
| 30 Sep 16 | 2 | -5 | 4 | 2 |
| 30 Jun 16 | 2 | -5 | 4 | 3 |
| 31 Mar 16 | 2 | -5 | 4 | 3 |
| 31 Dec 15 | 2 | -5 | 4 | 3 |
| 30 Sep 15 | 1 | -5 | 3 | 3 |
| 30 Jun 15 | 1 | -4 | 3 | 2 |
| 31 Mar 15 | 1 | -3 | 2 | 2 |
| 31 Dec 14 | 1 | -3 | 2 | 1 |
| 30 Sep 14 | 1 | -2 | 2 | 1 |
| 30 Jun 14 | 1 | -1 | 1 | 1 |
| 31 Mar 14 | 1 | -1 | 1 | 1 |
| 31 Dec 13 | 1 | -1 | 1 | 1 |
Quality Earnings: TLT is currently unprofitable.
Growing Profit Margin: TLT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TLT is unprofitable, but has reduced losses over the past 5 years at a rate of 7.7% per year.
Accelerating Growth: Unable to compare TLT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TLT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Return on Equity
High ROE: TLT has a negative Return on Equity (-265.89%), as it is currently unprofitable.